STOCK OPTIONS AND RESTRICTED SHARES (Tables)

12 Months Ended

Mar. 31, 2024

Share-Based Payment Arrangement [Abstract]

Summary of Stock-based Compensation

The following amounts of stock-based compensation expense for restricted shares were recorded (dollars in thousands):

	Fiscal Year Ended March 31,
	2024		2023		2022
Cost of product revenue	$	5	$	4	$	5
General and administrative		923		1,596		793
Sales and marketing		17		8		12
Research and development		5		4		3
	$	950	$	1,612	$	813

Summary of Outstanding Stock Options

The following table summarizes information with respect to outstanding stock options:

	Number of Shares			Weighted Average Exercise Price
Outstanding at March 31, 2023		73,136		$	2.41
Granted		—		$	—
Exercised		—		$	—
Forfeited		(73,136	)	$	2.41
Outstanding at March 31, 2024		—		$	—
Exercisable at March 31, 2024		—		$	—

Summary of performance-vesting restricted stock and time vesting-restricted stock

The following table summarizes information with respect to performance-vesting restricted stock and time vesting-restricted stock activity:

	Time-Based Restricted Shares					Performance-Based Restricted Shares
	Shares			Weighted Average Fair Value Price		Shares		Weighted Average Fair Value Price
Balance at March 31, 2023		612,819		$	2.82		130,635	$	2.15
Shares issued		677,090		$	1.42		577,742	$	1.55
Shares vested		(260,555	)	$	3.19		—		—
Shares forfeited		(15,250	)	$	2.01		—		—
Shares outstanding at March 31, 2024		1,014,104		$	1.87		708,377	$	1.66
Per share price on grant date	$0.95 - 1.55					$1.55 - 2.18

Summary of Unrecognized Compensation Cost Related to Non-vested Awards

Unrecognized compensation cost related to non-vested common stock-based compensation as of March 31, 2024 is expected to be recognized as follows (dollars in thousands):

Fiscal 2025	$	696
Fiscal 2026		384
Fiscal 2027		137
Thereafter		—
Total	$	1,217
Remaining weighted average expected term	2.1 years